Webinar Recording: Health Care Enforcement Year in Review & 2022 Outlook
In the first year of the Biden administration, health care fraud remained an enforcement priority for the Department of Justice (DOJ) and other federal agencies. While criminal enforcement actions continued to focus on the opioid crisis, the civil False Claims Act (FCA) is still one of the government’s most powerful enforcement tools. In our annual webinar, Mintz’s Health Care Enforcement Defense team reviewed the key health care fraud enforcement developments and trends from 2021, assessed their likely impact in 2022, and provided recommendations to avoid government scrutiny.
Topics included:
- Statistical analysis of trends in False Claims Act litigation involving the health care industry
- DOJ’s health care fraud enforcement priorities, including opioids, COVID-19, Medicare Advantage risk adjustment practices, telefraud, and misconduct in clinical trials
- Overview of federal agency guidance and policy developments in 2021, including the DOJ’s renewed focus on individual and corporate accountability
- Predictions for health care enforcement activity in 2022
Authors
Grady R. Campion
Associate
Grady R. Campion is a Mintz attorney who focuses his practice on complex commercial litigation and white collar matters. He represents clients in a variety of industries, including financial services.
Randy K. Jones
Member
Randy K. Jones is an esteemed trial lawyer who draws on extensive courtroom experience to help Mintz clients. He often negotiates efficient solutions well short of trial. Clients who need a seasoned courtroom practitioner have asked Randy to take charge of cases shortly before trials.
Samantha P. Kingsbury
Of Counsel
Samantha advises clients on regulatory and enforcement matters. She has deep experience handling violations of the federal ant-kickback statute and FCA investigations for clinical laboratories and hospitals.
Karen S. Lovitch
Chair, Health Law Practice & Chair, Health Care Enforcement Defense Practice
Karen advises industry clients on regulatory, transactional, operational, and enforcement matters. She has deep experience handling FCA investigations and qui tam litigation for laboratories and diagnostics companies.
Kevin M. McGinty
Member / Co-chair, Class Action Practice
Kevin is a member of the firm's Health Care Enforcement Defense Group and has significant experience representing health care–related entities in a variety of litigation matters, including contract, regulatory, False Claims Act and class action lawsuits. Kevin's health care industry clients have included pharmacies, PBMs, hospitals, clinical laboratories, diagnostic imaging providers, pharmaceutical companies and managed care organizations.